Silvia Marfil

Badalona, CT 08916, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species.

Comparison of Three Commercial ELISA Kits for Detection of Antibodies Against SARS-CoV-2 in Serum Samples from Different Animal Species.

Journal: Viruses
Published: April 09, 2025

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encounters.

Journal: Journal of translational medicine
Published: March 07, 2025

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic.

Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic.

Journal: Cell reports
Published: September 09, 2024

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides.

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides.

Journal: Frontiers in cellular and infection microbiology
Published: June 02, 2024

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.

Novel Spike-stabilized trimers with improved production protect K18-hACE2 mice and golden Syrian hamsters from the highly pathogenic SARS-CoV-2 Beta variant.

Journal: Frontiers in immunology
Published: September 10, 2023

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.

Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.

Journal: Nature communications
Published: April 21, 2023

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 28, 2023

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.

A monoclonal antibody targeting a large surface of the receptor binding motif shows pan-neutralizing SARS-CoV-2 activity.

Journal: Nature communications
Published: January 25, 2023

Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.

Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate.

Journal: Vaccine
Published: January 09, 2023

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates.

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates.

Journal: iScience
Published: December 13, 2022

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.

Impact of hybrid immunity booster vaccination and Omicron breakthrough infection on SARS-CoV-2 VOCs cross-neutralization.

Journal: iScience
Published: October 28, 2022

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors.

Journal: Molecular oncology
Published: August 09, 2022
Showing 1-12 of 39

Last Updated: 09/26/2026